| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
1
Department of Medicine, Division of Hematology, Karolinska Hospital and Institute, SE-171 76 Stockholm, Sweden.
a Author for correspondence. Hematological Lab, CMM, L8:03, Karolinska Hospital, SE-171 76 Stockholm, Sweden. Fax 468-5177-3054; e-mail
Dawei.Xu{at}cmm.ki.se.
Background: Telomerase is a ribonucleoprotein enzyme associated with immortalization and transformation of human cells. The telomeric repeat amplification protocol (TRAP) is widely used for the detection of telomerase activity. The TRAP method, although highly sensitive and specific because it includes PCR amplification, is laborious and does not provide precise quantitative information.
Methods: We developed a real-time quantitative TRAP (RTQ-TRAP) system by combining a real-time PCR technique with the conventional TRAP method. Telomerase activity in human tumor cell lines and in 13 lymphoma samples was measured using the RTQ-TRAP assay, and the results obtained from the samples using the RTQ-TRAP method were compared with the conventional TRAP method.
Results: The RTQ-TRAP method was both accurate and reproducible in measuring telomerase activity in a dilution series of protein extracts from HL60 cells. Telomerase activity in 13 lymphoma samples, as determined by the RTQ-TRAP method, was ninefold lower than that measured by the conventional TRAP method. The half-life of telomerase activity in human tumor cells, as determined using RTQ-TRAP, was much shorter than the half-life reported previously.
Conclusions: Our results suggest that the conventional TRAP assay frequently overestimates telomerase activity in tumor samples. The RTQ-TRAP method is thus a useful tool to rapidly and precisely quantify telomerase activity.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  A. Karystinou, F. Dell'Accio, T. B. A. Kurth, H. Wackerhage, I. M. Khan, C. W. Archer, E. A. Jones, T. A. Mitsiadis, and C. De Bari Distinct mesenchymal progenitor cell subsets in the adult human synovium Rheumatology, September 1, 2009; 48(9): 1057 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lou, X. Chen, M. Jalink, Q. Zhu, N. Ge, S. Zhao, X. Fang, Y. Fan, M. Bjorkholm, Z. Liu, et al. The Opposing Effect of Hypoxia-Inducible Factor-2{alpha} on Expression of Telomerase Reverse Transcriptase Mol. Cancer Res., August 1, 2007; 5(8): 793 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Matthews, I. Gorenne, S. Scott, N. Figg, P. Kirkpatrick, A. Ritchie, M. Goddard, and M. Bennett Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis: Effects of Telomerase and Oxidative Stress Circ. Res., July 21, 2006; 99(2): 156 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ayyanan, G. Civenni, L. Ciarloni, C. Morel, N. Mueller, K. Lefort, A. Mandinova, W. Raffoul, M. Fiche, G. P. Dotto, et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism PNAS, March 7, 2006; 103(10): 3799 - 3804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. I. Botchkina, R. H. Kim, I. L. Botchkina, A. Kirshenbaum, Z. Frischer, and H. L. Adler Noninvasive Detection of Prostate Cancer by Quantitative Analysis of Telomerase Activity Clin. Cancer Res., May 1, 2005; 11(9): 3243 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Fu, J. Quintero, and C. C. Baker Keratinocyte Growth Conditions Modulate Telomerase Expression, Senescence, and Immortalization by Human Papillomavirus Type 16 E6 and E7 Oncogenes Cancer Res., November 15, 2003; 63(22): 7815 - 7824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dikmen, E. Dikmen, M. Kara, E. Sahin, P. Dogan, and N. Ozdemir Diagnostic implications of telomerase activity in pleural effusions Eur. Respir. J., September 1, 2003; 22(3): 422 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Su, J. Vieweg, A. Z. Weizer, P. Dahm, D. Yancey, V. Turaga, J. Higgins, D. Boczkowski, E. Gilboa, and J. Dannull Enhanced Induction of Telomerase-specific CD4+ T Cells Using Dendritic Cells Transfected with RNA Encoding a Chimeric Gene Product Cancer Res., September 1, 2002; 62(17): 5041 - 5048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Q. Xu, M. He, H.-P. Yu, X.-Y. Wang, X.-L. Tan, B. Lu, X. Sun, Y.-K. Zhou, Q.-F. Yao, Y.-J. Xu, et al. Bioluminescent Method for Detecting Telomerase Activity Clin. Chem., July 1, 2002; 48(7): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wege, M. S. Chui, H. T. Le, J. M. Tran, and M. A. Zern SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity Nucleic Acids Res., January 15, 2002; 31(2): e3 - e3. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Hess and W. E. Highsmith Jr Telomerase Detection in Body Fluids Clin. Chem., January 1, 2002; 48(1): 18 - 24. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
